Skip to main content

AIM ImmunoTech Inc.

For the period ended Mar 31, 2026. Filed May 15, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 15, 2026

AIM$0.16+1.3%Stored close · as of Nov 9, 2026

What changed in Risk Factors?

Read the current filing

Comparison unavailable

The comparison is taking longer than usual or could not load. Reload to try again, or open the filing text.

Unavailable is not the same as unchanged.